In vitro morphological profiling of T cells predicts clinical response to natalizumab therapy in patients with multiple sclerosis. - Chaves B; Santos E Silva JC; Nakaya H; Socquet-Juglard N; Bucciarelli F; Prunier G; Almeida MV; Lacouture C; Kari S; Astier AL; Medeiros MA; Silva JHM; et al. (Nature communications, 2025)